• US Congress will debate over new coronavirus aid bill
• 4th day of the EU summit
Major European indices finished session mostly higher as investors await the outcome of the EU summit after leaders failed to reach an agreement on the €750 recovery fund during the weekend. Some Member States do not like the high amounts of grants that would be awarded to individual countries affected by the pandemic. European Council President Charles Michel proposed a new figure of €390 billion in grants combined with smaller rebate, down from an initial proposal of €400 billion, but higher than the €350 billion proposed by Austria, Denmark, Sweden, and the Netherlands. On the earnings front, Renault reported a massive 34.9% drop in sales, however company sees signs of recovery in June. Meantime Volvo (VOLVB.SE) and Ericsson (ERICB.SE) posted better than expected results.
Recent news regarding potential COVID-19 vaccine lifted market sentiment. German biotech firm BioNTech (BNTX.US), US drugmaker Pfizer (PFE.US) and Oxford-AstraZaneca (AZN.UK) reported promising results in early human testing. During today’s session DAX rose 1%, CAC 40 gained 0.3%. FTSE 100 finished 0.5% lower as investors await any new development on Brexit talks or the EU Recovery Plan. In case if the UK and the EU won't be able to reach an agreement on their future relationship, tariffs and quotas will be re-imposed when the UK leaves the bloc at the year-end.
GBPUSD – British pound is one of the strongest currencies among majors during today’s session. Cable is approaching major resistance zone at 1.2676 which is additionally strengthened by 200 MA (redline). In case of a break higher, the next resistance to watch is located at 1.2817. However if sellers will manage to take control on the market, then downward move into 1.2480 is possible. Source: xStation5US100 loses 0.5% 📉Meta shares decline extends on AI CAPEX worries & Deutsche Bank remarks
CHN.cash under pressure despite positive Trump remarks 🚩
⏬EURUSD the lowest in 3 months
Wall Street optimism tempers amid falling odds of December Fed rate cut